The Lessons of Asilomar for Today’s Science
By Alexander Capron,
The New York Times
| 05. 28. 2015
Untitled Document
There is a precedent for establishing internationally agreed-upon limits for new science, though it can be hard to do.
In 1973, scientists who were using novel molecular techniques to splice DNA between different organisms asked the National Academy of Sciences to consider the potential hazards as they might affect the public. In July 1974, an Academy-appointed committee publicly called for a large category of experiments to be suspended until leaders in the field could plan a way forward. Such a self-imposed moratorium on basic research was unprecedented, but it worked.
A hundred and fifty scientists and physicians from around the world gathered in February 1975 at the Asilomar conference center near Monterey, California, in what one scientist termed an amazing show of “self denial and social responsibility in the face of strong intellectual temptation” to continue the experiments.
The outcome of the meeting was equally impressive. Categories of experiments were graded by their riskiness: Some were deemed excessively dangerous and kept off-limits, while others were to be allowed once the appropriate biological and physical means of risk-containment had...
Related Articles
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...